Bovine haemoglobin is more potent than autologous red blood cells in restoring muscular tissue oxygenation after profound isovolaemic haemodilution in dogs

Canadian Journal of Anaesthesia

Volumn 43, Issue 7, 1996, Pages 714-723

  Standl, T ^a   Horn, P ^a   Wilhelm, S ^a   Greim, C ^a   Freitag, M ^a   Freitag, U ^a   Sputtek, A ^b   Jacobs, E ^c   Schulte Am Esch, J ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b Department of Transfusion Medicine   (United States)

^c Biopure Corporation   (United States)

Author keywords

BLOOD:haemodilution; bovine haemoglobin; OXYGEN:transport; TRANSFUSlON:autologous

Indexed keywords

HEMOGLOBIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL OXYGEN TENSION; ARTICLE; BLOOD AUTOTRANSFUSION; CONTROLLED STUDY; COW; DOG; ERYTHROCYTE; HEART INDEX; HEART RATE; HEMODILUTION; HEMODYNAMICS; MUSCLE TISSUE; NONHUMAN; OXYGEN TRANSPORT; POLAROGRAPHY; PRIORITY JOURNAL; SKELETAL MUSCLE; TISSUE OXYGENATION; VASCULAR RESISTANCE;

EID: 0029766826     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03017957     Document Type: Article

References (39)

1. Chang TMS, Varma R. Assessment of blood substitutes: I. Efficacy studies in anesthetized and conscious rats with loss of 1/3, 1/2 and 2/3 blood volume. Artif Cells Blood Substit Immobil Biotechnol 1994; 22: 159-69.
2. Harringer W, Hodakowski GT, Svizzero T, Jacobs EE, Vlahakes GJ. Acute effects of massive transfusion of a bovine hemoglobin blood substitute in a canine model of hemorrhagic shock. Eur J Cardiothorac Surg 1992; 6: 649-54.
3. Looker D, Abbott-Brown D, Cozart P, et al. A human recombinant haemoglobin designed for use as a blood substitute. Nature 1992; 356: 258-60.
4. Lee R, Atsumi N, Jacobs EE Jr, Austen WC, Vlahakes GJ. Ultrapure, stroma-free, polymerized bovine hemoglobin solution: evaluation of renal toxicity. J Surg Res 1989; 47: 407-11.
5. Urbaitis BK, Razynska A, Corteza Q, Fronticelli C, Bucci E. Intravascular retention and renal handling of purified natural and intramolecularly cross-liked hemoglobins. J Lab Clin Med 1990; 117: 115-21.
6. Fronticelli C, Bucci E, Orth C. Solvent regulation of oxygen affinity in hemoglobin. J Biol Chem 1984; 259: 10841-4.
7. Bosman RJ, Minten J, Lu HR, Van Aken H, Flameng W. Free polymerized hemoglobin versus hydroxyethyl starch in resuscitation of hypovolemic dogs. Anesth Analg 1992; 75: 811-7.
8. Vlahakes GJ, Lee R, Jacobs EE Jr, LaRaia PJ, Austen WG. Hemodynamic effects and oxygen transport properties of a new blood substitute in a model of massive blood replacement. J Thorac Cardiovasc Surg 1990; 100: 379-88.
9. Hobbhahn J, Vogel H, Kothe N, Brendel W, Peter K, Jesch F. Hemodynamics and oxygen transport after partial and total blood exchange with pyridoxalated polyhemoglobin in dogs. Acta Anaesthesiol Scand 1985; 29: 537-43.
10. Jesch FH, Peters W, Hobbhahn J, Schoenberg M, Messmer K. Oxygen-transporting fluids and oxygen delivery with hemodilution. Crit Care Med 1982; 10: 270-4.
11. Standt Th, Reeker W, Kochs E, Schulte am Esch J. Tissue oxygenation changes in skeletal muscle during complete isovolumic haemodilution with a bovine haemoglobin solution compared with 6% hydroxyethyl starch 200,000/0.5. (German) Anaesthesist 1994; 43 (Suppl): 800-1.
12. Federspiel WJ, Popel AS. A theoretical analysis of the effect of the particulate nature of blood on oxygen release in capillaries. Microvasc Res 1986; 32: 164-89.
13. Honig CR, Frierson JL, Gayeski TEJ. Anatomical determinants of O2 flux density at coronary capillaries. Am J Physiol 1989; 256: 375-82.
14. 2 histograms from rabbit hind-limb muscles obtained by simultaneous measurements with hypodermic needle electrodes and with surface electrodes. Adv Exp Med Biol 1984; 169: 447-55.
15. 2 observed in dog gracilis muscle. In: Ehrly AM, Hauss J, Huch R (Eds.). Clinical Oxygen Pressure Measurement I. Berlin: Blackwell Ueberreuter Wissenschaft, 1990: 256-67.
16. Boekstegers P, Weidenhöfer S, Kapsner T, Werdan K. Skeletal muscle partial pressure of oxygen in patients with sepsis. Crit Care Med 1994; 22: 640-50.
17. Schulte am Esch J, Bause HW, Kochs E. Influences of various respiratory and circulatory conditions on muscle tissue oxygenation in critically ill patients. In: Vincent J-L (Ed.). Yearbook of Intensive Care and Emergency Medicine. Berlin: Springer-Verlag, 1992: 303-9.
18. Breepoel PM, Kreuzer F, Hazevoet M. Interaction of organic phosphates with bovine hemoglobin. I. Oxylabile and phosphate-labile proton binding. Pflügers Arch 1981; 389: 219-25.
19. Brewer GJ, Eaton JW. Erythrocyte metabolism: interaction with oxygen transport. Science 1971; 171: 1205-11.
20. Walker WH, Netz M, Gänshirt KH. 49 day storage of erythrocyte concentrates in blood bags with the PAGGS-mannitol solution. (German). Beitraege zur Infusionstherapie 1990; 26: 55-9.
21. Simon ER. Red cell preservation: further studies with adenine. Blood 1962; 20: 485-91.
22. Valtis DJ, Kennedy AC. Defective gas-transport function of stored red blood-cells. Lancet 1954; 1: 119-24.
23. Chapman RG, Rettberg WAH, Dougherty S. Effect of initial storage at room temperature on human red blood cell ATP, 2,3-DPG, and viability. Transfusion 1977; 17: 147-50.
24. Hamasaki N, Hirota C, Ideguchi H, Ikehara Y. Regeneration of 2,3-bisphosphoglycerate and ATP of stored erythrocytes by phosphoenolpyruvate, a new preservative for blood storage. Prog Clin Biol Res 1981; 55: 577-94.
25. Beutler E, Meul A, Wood LA. Depletion and regeneration of 2,3-diphosphoglyceric acid in stored red cells. Transfusion 1969; 9: 109-14.
26. Federspiel WJ. Pulmonary diffusing capacity: implications of two-phase blood flow in capillaries. Respir Physiol 1989; 77: 119-34.
27. Biro GP, Taichmann GC, Lada B, Keon WJ, Rosen AL, Sehgal LR. Coronary vascular actions of stroma-free hemoglobin preparations. Artif Organs 1988; 12: 40-50.
28. Vogel WM, Dennis RC, Cassidy G, Apstein CS, Valeri CR. Coronary constrictor effect of stroma-free hemoglobin solutions. Am J Physiol 1986; 251: H 413-20.
29. Gilroy D, Shaw C, Parry E, Olding-Smee W. Detection of a vasoconstrictor factor in stroma-free haemoglobin solutions. J Trauma 1988; 28: 1312-6.
30. Hodakowski GT, Page RD, Harringer W, et al. Ultra-pure polymerized bovine hemoglobin blood substitute: effects on the coronary circulation. Biomaterials Artificial Cells, & Immobilization Biotechnology 1992; 20: 669-72.
31. Kreuger A, Akerblom O. Adenine consumption in stored citrate-phosphate-dextrose-adenine blood. Vox Sang 1980; 38: 156-60.
32. Åkerblom O, Kreuger A. Studies on citrate-phosphate-dextrose (CPD) blood supplemented with adenine. Vox Sang 1975; 29: 90-5.
33. Sputtek A, Singbartl G, Langer R, Schleimer W, Henrich HA, Khnl P. Cryopreservation of red blood cells with the non-penetrating cryoprotectant hydroxyethyl starch. Cryo-Letters 1995; 16: 283-8.
34. Brückner UB, Messmer K. Organ blood supply and oxygenation during limited isovolemic hemodilution with 6% HES 200/0.62 and 6% dextran-70. (German). Anaesthesist 1991; 40: 434-40.
35. Cole DJ, Schell RM, Drummond JC, Reynolds L. Focal cerebral ischemia in rats. Effect of hypervolemic hemodilution with diaspirin cross-linked hemoglobin versus albumin on brain injury and edema. Anesthesiology 1993; 78: 335-42.
36. Gonzalez P, Hackney AC, Jacobs EE, Hughes GS, Orringer EP. A phase I/II study of polymerized bovine hemoglobin (PBH) in adult patients with sickle cell disease (SCD) not in crisis. Blood 1994; 84: 413a.
37. Hughes G Jr, Jacobs E Jr, Yancey B, et al. Hemoglobin-based oxygen carrier preserves oxygen delivery and exercise capacity in humans. Crit Care Med 1995; 23: A86.
38. Hughes G Jr, Jacobs E Jr, Antal E, et al. Pharmacokinetics of a novel hemoglobin-based oxygen carrier in humans. Crit Care Med 1995; 23: A257.
39. Monk T, Goodnough L, Hughes G Jr, Jacobs E Jr. Evaluation of the safety and tolerance of hemoglobin-based oxygen carrier-201. Anesthesiology 1995; 83: A285.